Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00011843 · ClinicalTrials.gov registry record

Molecular Analysis of Microphthalmia/Anophthalmia

A clinical trial, sponsored by National Human Genome Research Institute (NHGRI).

Completed
Registry status
450
Enrollment target

NCT00011843: Completed study, sponsored by National Human Genome Research Institute (NHGRI).

NCT00011843 is a clinical trial that has completed, run by National Human Genome Research Institute (NHGRI). The registered enrollment target is 450 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00011843 has completed, sponsored by National Human Genome Research Institute (NHGRI).

COMPLETED
Registry status
450 participants
Enrollment target

Study Summary

This study will try to learn more about the genetic cause and symptoms of microphthalmia (small eyes) or anophthalmia (absence of one or both eyes). Patients with microphthalmia or anophthalmia with mental retardation may be eligible for this study. Patients' parents and siblings will also be included for genetic studies. Patients may participate in both the clinical and laboratory parts of the study or just the laboratory part, as described below: Laboratory The laboratory study consists of DNA analysis to determine the genetic cause of microphthalmia/anophthalmia. The DNA sample is obtained using one of the following methods: * Blood draw - for young children, a numbing cream is applied to the skin before the needlestick to decrease the pain * Skin biopsy - a small piece of skin (about 1/8-inch in diameter) is removed surgically after the area has been numbed with an anesthetic * Cotton swab - a specimen is collected from inside the cheek using a cotton swab. This is done only for patients who cannot provide a blood or skin sample. * Prenatal sample - If, in the case of newborns, specimens are left from prenatal testing, these can be used instead of a blood sample. Some patients may have a permanent cell line grown from the blood or skin sample for use in future research tests. Clinical For the clinical study, participants undergo some or all of the following procedures at the NIH Clinical Center: * Physical examination * Clinical photographs, X-rays, blood tests * Magnetic resonance imaging (MRI) scan of the brain - a diagnostic procedure that uses a magnetic field and radio waves instead of X-rays to produce images of the brain

Trial Details

FieldValue
Enrollment Target 450 participants
Start Date 2001-02-22
Est. Completion 2009-02-04

What the finished NCT00011843 record still lists

NCT00011843 is an observational study that tracks outcomes without assigning an intervention. The registered 450 participants enrollment target is mid-sized for trials with a published cap.

The record links to 0 conditions, and to 0 interventions.

NCT00011843 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00011843 about?

NCT00011843 is a clinical study titled "Molecular Analysis of Microphthalmia/Anophthalmia". This study will try to learn more about the genetic cause and symptoms of microphthalmia (small eyes) or anophthalmia (absence of one or both eyes). Patients with microphthalmia or anophthalmia with mental retardation may be eligible for this study. Patients' parents and siblings will also be inclu...

What is the current status of trial NCT00011843?

This trial is currently completed. The enrollment target is 450 participants. The study started on 2001-02-22. Estimated completion is 2009-02-04.

Who is sponsoring clinical trial NCT00011843?

This trial is sponsored by National Human Genome Research Institute (NHGRI), which has 185 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00515060 · 450 participants

    Psychophysical Studies of Cancer Therapy Pain

  • NCT01257269 · 450 participants

    Genotype and Phenotype Correlation in Hereditary Thrombotic Thrombocytopenic Purpura (Upshaw-Schulman Syndrome)

  • NCT03047161 · 450 participants

    Electrophysiology of Fetal Arrhythmia

  • NCT03269630 · 450 participants

    New Orleans Pulmonary Hypertension Biobank

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT00011843, the US trial registry maintained by the National Library of Medicine. NCT00011843 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.